17-06-2026 16:56 via nytimes.com

The New Race to Find Treatments for Measles

As vaccination rates decline, biotech companies see a potential new market for measles drugs.

Read more »

Europe Hurries to Fund More Cutting-Edge Businesses to Compete with China and U.S.

After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada

Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research

Chemical actuation expands the design space of living light materials

Mary-Dell Chilton Dies at 87; Helped Create First Genetically Modified Plant

Programmable mycolysins expand the antimicrobial toolkit against mycobacteria

With Measles Roaring Back, the Search for a Drug is On

Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here

As Ebola Spreads in East Africa, Will China Step Up?

J. Craig Venter (1946—2026)

China’s Rise in Drug Development Looms Over U.S.

Reprogramming halophilic life for low-salt biomanufacturing

Biotechnologies based on the fungal bioluminescence pathway

Blue at the edge